Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Two giants of the health care industry, Pfizer and Allergan, announced Monday that they will merge to create the world's largest drug maker in terms of sales. Pfizer will buy Allergan, the maker of products like Botox, for $160 billion.
The deal could allow New York-based Pfizer to move its headquarters to Dublin, where Allergan is based, and avoid high U.S. corporate tax rates. As noted in the companies' shared release, the "combined company is expected to maintain Allergan's Irish legal domicile."
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in